The therapeutic efficiency of recombinant thymosin β4 (rTβ4) synthesized by us was studied in vivo on spontaneous CBRB mouse model that is adequate to human chronic dermatitis. Three applications of the drug during a week significantly alleviated symptoms of the disease in female mice, and in complex with subsequent antibacterial and antifungal therapy led to a pronounced and lasting (2 months) therapeutic effect. The results attest to a possibility of using rTβ4 in combination with the known treatment protocols for chronic inflammatory diseases of the skin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
K. A. Beirakhova, V. N. Stepanenko, A. I. Miroshnikov, and R. S. Esipov, Bioorgan. Khim., 37, No. 2, 223–232 (2011).
E. V. Moiseeva, E. A. Ustyugova, S. G. Semushina, et al., Fundament. Issled., No. 6–2, 333–337 (2012).
D. S. Grant, J. L. Kinsella, M. C. Kibbey, et al., J. Cell Sci., 108, Pt. 12, 3685–3694 (1995).
R. Hinkel, C. El-Aouni, T. Olson, et al., Circulation, 117, No. 17, 2232–2240 (2008).
H. G. Mannherz and E. Hannappel, Cell. Motil. Cytoskeleton, 66, No. 10, 839–851 (2009).
E. Moiseeva, Anti-Breast Cancer Drug Testing. Original Approaches. Novel Set of Mouse Models, LAP (2009), P. 220.
D. Philp, M. Badamchian, B. Scheremeta, et al., Wound Rep. Reg., 11, No. 1, 19–24 (2003).
D. Philp, T. Huff, Y. S. Gho, et al., FASEB J., 17, No. 14, 2103–2105 (2003).
D. Philp, M. Nguen, B. Scheremeta, et al., FASEB J., 18, No. 2, 385–387 (2004).
G. Sosne, C. C. Chan, K. Thai, et al., Exp. Eye Res., 72, No. 5, 605–608 (2001).
G. Sosne, P. Qiu, P. L. Christopherson, and M. K. Wheater, Exp. Eye Res., 84, No. 4, 663–669 (2007).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 158, No. 11, pp. 620–623, November, 2014
Rights and permissions
About this article
Cite this article
Moiseeva, E.V., Beirakhova, K.A., Semushina, S.G. et al. Efficiency of Recombinant Thymosin β4 in Spontaneous Mouse Model of Chronic Dermatitis. Bull Exp Biol Med 158, 670–672 (2015). https://doi.org/10.1007/s10517-015-2831-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-015-2831-y